Redox regulation of nuclear post-translational modifications during NF-κB activation

Antioxidants and Redox Signaling

Volumn 11, Issue 9, 2009, Pages 2209-2222

  Gloire, Geoffrey ^a   Piette, Jacques ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; HISTONE DEACETYLASE; I KAPPA B; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SERINE; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR RECEPTOR; TYROSINE;

CHROMATIN ASSEMBLY AND DISASSEMBLY; CIGARETTE SMOKING; DNA BINDING; HUMAN; NITRATION; NITROSYLATION; NONHUMAN; OXIDATION REDUCTION REACTION; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVIEW;

CELL NUCLEUS; HYDROGEN PEROXIDE; NF-KAPPA B; OXIDATION-REDUCTION; PROTEIN PROCESSING, POST-TRANSLATIONAL; REACTIVE OXYGEN SPECIES;

EID: 68949196898     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2463     Document Type: Review

References (99)

1. Adenuga D, Yao H, March TH, Seagrave J, and Rahman I. Histone deacetylase 2 is phosphorylated, ubiquitinated and degraded by cigarette smoke. Am J Respir Cell Mol Biol 40: 464-473, 2009.
2. Ando K, Hirao S, Kabe Y, Ogura Y, Sato I, Yamaguchi Y, Wada T, and Handa H. A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity. Nucleic Acids Res 36: 4327-4336, 2008.
3. Anest V, Hanson JL, Cogswell PC, Steinbrecher KA, Strahl BD, and Baldwin AS. A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature 423: 659-663, 2003.
4. Arenzana-Seisdedos F, Thompson J, Rodriguez MS, Bachelerie F, Thomas D, and Hay RT. Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. Mol Cell Biol 15: 2689-2696, 1995.
5. Arenzana-Seisdedos F, Turpin P, Rodriguez M, Thomas D, Hay RT, Virelizier JL, and Dargemont C. Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J Cell Sci 110: 369-378, 1997.
6. Aruoma OI, Halliwell B, Hoey BM, and Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 6: 593-597, 1989.
7. Ashburner BP, Westerheide SD, and Baldwin AS, Jr. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressorsHDAC1 andHDAC2 to negatively regulate gene expression.Mol Cell Biol 21: 7065-7077, 2001.
8. Bader M, Muse W, Ballou DP, Gassner C, and Bardwell JC. Oxidative protein folding is driven by the electron transport system. Cell 98: 217-227, 1999.
9. Beraud C, Henzel WJ, and Baeuerle PA. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation. Proc Natl Acad Sci USA 96: 429-434, 1999.
10. Bonizzi G and Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25: 280-288, 2004.
11. Bui NT, Livolsi A, Peyron JF, and Prehn JH. Activation of nuclear factor kappaB and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IkappaBalpha. J Cell Biol 152: 753-764, 2001.
12. Calao M, Burny A, Quivy V, Dekoninck A, and Van Lint C. A pervasive role of histone acetyltransferases and deacetylases in an NF-kappaB-signaling code. Trends Biochem Sci 33: 339-349, 2008.
13. Chen L, Fischle W, Verdin E, and Greene WC. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293: 1653-1657, 2001.
14. Chen LF, Mu Y, and Greene WC. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J 21: 6539-6548, 2002.
15. Chen LF, Williams SA, Mu Y, Nakano H, Duerr JM, Buckbinder L, and Greene WC. NF-kappaB RelA phosphorylation regulates RelA acetylation. Mol Cell Biol 25: 7966-7975, 2005.
16. Church DF and Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64: 111-126, 1985.
17. Culpitt SV, Rogers DF, Shah P, De Matos C, Russell RE, Donnelly LE, and Barnes PJ. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167: 24-31, 2003.
18. Dejardin E. The alternative NF-kappaB pathway from biochemistry to biology: Pitfalls and promises for future drug development. Biochem Pharmacol 72: 1161-1179, 2006.
19. Demple B, Herman T, and Chen DS. Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease: Definition of a family of DNA repair enzymes. Proc Natl Acad Sci USA 88: 11450-11454, 1991.
20. Dong J, Jimi E, ZhongH,HaydenMS, andGhosh S. Repression of gene expression by unphosphorylated NF-kappaB p65 through epigeneticmechanisms. GenesDev 22: 1159-1173, 2008.
21. Duran A, Diaz-Meco MT, and Moscat J. Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation. EMBO J 22: 3910-3918, 2003.
22. Enesa K, Ito K, Luong le A, Thorbjornsen I, Phua C, To Y, Dean J, Haskard DO, Boyle J, Adcock I, and Evans PC. Hydrogen peroxide prolongs nuclear localization of NF-kappaB in activated cells by suppressing negative regulatory mechanisms. J Biol Chem 283: 18582-18590, 2008.
23. Enesa K, Zakkar M, Chaudhury H, Luong le A, Rawlinson L, Mason JC, Haskard DO, Dean JL, and Evans PC. NF-kappaB suppression by the deubiquitinating enzyme Cezanne: A novel negative feedback loop in pro-inflammatory signaling. J Biol Chem 283: 7036-7045, 2008.
24. Fishel ML and Kelley MR. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. Mol Aspects Med 28: 375-395, 2007.
25. Gallagher D, Gutierrez H, Gavalda N, O'Keeffe G, Hay R, and Davies AM. Nuclear factor-kappaB activation via tyrosine phosphorylation of inhibitor kappaB-alpha is crucial for ciliary neurotrophic factor-promoted neurite growth from developing neurons. J Neurosci 27: 9664-9669, 2007.
26. Garcia-Pineres AJ, Castro V, Mora G, Schmidt TJ, Strunck E, Pahl HL, and Merfort I. Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J Biol Chem 276: 39713-39720, 2001.
27. Ghosh S and Hayden MS. New regulators of NF-kappaB in inflammation. Nat Rev Immunol 8: 837-848, 2008.
28. Gloire G, Charlier E, Rahmouni S, Volanti C, Chariot A, Erneux C, and Piette J. Restoration of SHIP-1 activity in human leukemic cells modifies NF-kappaB activation pathway and cellular survival upon oxidative stress. Oncogene 25: 5485-5494, 2006.
29. Gloire G, Dejardin E, and Piette J. Extending the nuclear roles of IkappaB kinase subunits. Biochem Pharmacol 72: 1081-1089, 2006.
30. Gloire G, Horion J, El Mjiyad N, Bex F, Chariot A, Dejardin E, and Piette J. Promoter-dependent effect of IKKalpha on NF-kappaB/p65 DNA binding. J Biol Chem 282: 21308-21318, 2007.
31. Gloire G, Legrand-Poels S, and Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 72: 1493-1505, 2006.
32. Hayden MS and Ghosh S. Shared principles in NF-kappaB signaling. Cell 132: 344-362, 2008.
33. Hiramoto M, Shimizu N, Sugimoto K, Tang J, Kawakami Y, Ito M, Aizawa S, Tanaka H, Makino I, and Handa H. Nuclear targeted suppression of NF-kappa B activity by the novel quinone derivative E3330. J Immunol 160: 810-819, 1998.
34. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, and Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci USA 94: 3633-3638, 1997.
35. Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, Mori K, and Yodoi J. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem 274: 27891-27897, 1999.
36. Hoberg JE, Popko AE, Ramsey CS, and Mayo MW. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Mol Cell Biol 26: 457-471, 2006.
37. Hoberg JE, Yeung F, and Mayo MW. SMRT derepression by the IkappaB kinase alpha: a prerequisite to NF-kappaB transcription and survival. Mol Cell 16: 245-255, 2004.
38. Hoffmann A, Natoli G, and Ghosh G. Transcriptional regulation via the NF-kappaB signaling module. Oncogene 25: 6706-6716, 2006.
39. Huang WC, Ju TK, Hung MC, and Chen CC. Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB. Mol Cell 26: 75-87, 2007.
40. Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, and Adcock IM. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med 203: 7-13, 2006.
41. Jamaluddin M, Wang S, Boldogh I, Tian B, and Brasier AR. TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway. Cell Signal 19: 1419-1433, 2007.
42. Kabe Y, Ando K, Hirao S, Yoshida M, and Handa H. Redox regulation of NF-kappaB activation: Distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 7: 395-403, 2005.
43. Kato T, Jr., Delhase M, Hoffmann A, and Karin M. CK2 Is a C-Terminal IkappaB Kinase Responsible for NF-kappaB Activation during the UV Response. Mol Cell 12: 829-839, 2003.
44. Kehrer JP. The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 149: 43-50, 2000.
45. Kelleher ZT, Matsumoto A, Stamler JS, and Marshall HE. NOS2 regulation of NF-kappaB by S-nitrosylation of p65. J Biol Chem 282: 30667-30672, 2007.
46. Laga M, Cottyn A, Van Herreweghe F, Vanden Berghe W, Haegeman G, Van Oostveldt P, Vandekerckhove J, and Vancompernolle K. Methylglyoxal suppresses TNF-alpha-induced NF-kappaB activation by inhibiting NF-kappaB DNA-binding. Biochem Pharmacol 74: 579-589, 2007.
47. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189, 2004.
48. Lee JH, Koo TH, Hwang BY, and Lee JJ. Kaurane diterpene, kamebakaurin, inhibits NF-kappa B by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-kappa B target genes. J Biol Chem 277: 18411-18420, 2002.
49. Liang MC, Bardhan S, Pace EA, Rosman D, Beutler JA, Porco JA, Jr., and Gilmore TD. Inhibition of transcription factor NF-kappaB signaling proteins IKKbeta and p65 through specific cysteine residues by epoxyquinone A monomer: Correlation with its anti-cancer cell growth activity. Biochem Pharmacol 71: 634-645, 2006.
50. Lluis JM, Buricchi F, Chiarugi P, Morales A, and Fernandez-Checa JC. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: Activation of nuclear factor-κB via c-SRC and oxidant-dependent cell death. Cancer Res 67: 7368-7377, 2007.
51. Matthews JR, Botting CH, Panico M, Morris HR, and Hay RT. Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res 24: 2236-2242, 1996.
52. Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, and Hay RT. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res 20: 3821-3830, 1992.
53. Meja KK, Rajendrasozhan S, Adenuga D, Biswas SK, Sundar IK, Spooner G, Marwick JA, Chakravarty P, Fletcher D, Whittaker P, Megson IL, Kirkham PA, and Rahman I. Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. Am J Respir Cell Mol Biol 39: 312-323, 2008.
54. Muller FL, Liu Y, and Van Remmen H. Complex III releases superoxide to both sides of the inner mitochondrial membrane. J Biol Chem 279: 49064-49073, 2004.
55. Nagakawa J, Hishinuma I, Hirota K, Miyamoto K, Yamanaka T, Yamatsu I, and Katayama K. Protective effects of E3330, a novel quinone derivative, on galactosamine/tumor necrosis factor-alpha-induced hepatitis in mice. Eur J Pharmacol 229: 63-67, 1992.
56. Natoli G, Saccani S, Bosisio D, and Marazzi I. Interactions of NF-kappaB with chromatin: The art of being at the right place at the right time. Nat Immunol 6: 439-445, 2005.
57. Nishi T, Shimizu N, Hiramoto M, Sato I, Yamaguchi Y, Hasegawa M, Aizawa S, Tanaka H, Kataoka K, Watanabe H, and Handa H. Spatial redox regulation of a critical cysteine residue of NF-kappa B in vivo. J Biol Chem 277: 44548-44556, 2002.
58. Nowak DE, Tian B, Jamaluddin M, Boldogh I, Vergara LA, Choudhary S, and Brasier AR. RelA Ser276 phosphorylation is required for activation of a subset of NF-kappaB-dependent genes by recruiting cyclin-dependent kinase 9/cyclin T1 complexes. Mol Cell Biol 28: 3623-3638, 2008.
59. O'Shea JM and Perkins ND. Regulation of the RelA (p65) transactivation domain. Biochem Soc Trans 36: 603-608, 2008.
60. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18: 6853-6866, 1999.
61. Park SW, Huq MD, Hu X, and Wei LN. Tyrosine nitration on p65: a novel mechanism to rapidly inactivate nuclear factor-kappaB. Mol Cell Proteomics 4: 300-309, 2005.
62. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8: 49-62, 2007.
63. Perkins ND. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25: 6717-6730, 2006.
64. Raffoul JJ, Banerjee S, Singh-Gupta V, Knoll ZE, Fite A, Zhang H, Abrams J, Sarkar FH, and Hillman GG. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo. Cancer Res 67: 2141-2149, 2007.
65. Rahman I and MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 16: 534-554, 2000.
66. Rajendrasozhan S, Yang SR, Edirisinghe I, Yao H, Adenuga D, and Rahman I. Deacetylases and NF-kappaB in redox regulation of cigarette smoke-induced lung inflammation: Epigenetics in pathogenesis of COPD. Antioxid Redox Signal 10: 799-811, 2008.
67. Robson CN and Hickson ID. Isolation of cDNA clones encoding a human apurinic/apyrimidinic endonuclease that corrects DNA repair and mutagenesis defects in E. coli xth (exonuclease III) mutants. Nucleic Acids Res 19: 5519-5523, 1991.
68. Romieu-Mourez R, Landesman-Bollag E, Seldin DC, and Sonenshein GE. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells. Cancer Res 62: 6770-6778, 2002.
69. Roos D, van Bruggen R, and Meischl C. Oxidative killing of microbes by neutrophils. Microbes Infect 5: 1307-1315, 2003.
70. Sandur SK, Ichikawa H, Sethi G, Ahn KS, and Aggarwal BB. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) suppresses NF-kappaB activation and NF-kappaB-regulated gene products through modulation of p65 and IkappaBalpha kinase activation, leading to potentiation of apoptosis induced by cytokine and chemotherapeutic agents. J Biol Chem 281: 17023-17033, 2006.
71. Santos NC, Figueira-Coelho J, Martins-Silva J, and Saldanha C. Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol 65: 1035-1041, 2003.
72. Scheidereit C. IkappaB kinase complexes: Gateways to NFkappaB activation and transcription. Oncogene 25: 6685-6705, 2006.
73. Schoonbroodt S, Ferreira V, Best-Belpomme M, Boelaert JR, Legrand-Poels S, Korner M, and Piette J. Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of I kappa B alpha in NF-kappa B activation by an oxidative stress. J Immunol 164: 4292-4300, 2000.
74. Schreck R, Rieber P, and Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10: 2247-2258, 1991.
75. Sethi G, Ahn KS, and Aggarwal BB. Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res 6: 1059-1070, 2008.
76. Sethi G, Ahn KS, Chaturvedi MM, and Aggarwal BB. Epidermal growth factor (EGF) activates nuclear factor-kappaB through IkappaBalpha kinase-independent but EGF receptor-kinase dependent tyrosine 42 phosphorylation of IkappaBalpha. Oncogene 26: 7324-7332, 2007.
77. Shen J, Channavajhala P, Seldin DC, and Sonenshein GE. Phosphorylation by the protein kinase CK2 promotes calpain-mediated degradation of IkappaBalpha. J Immunol 167: 4919-4925, 2001.
78. Shimizu N, Sugimoto K, Tang J, Nishi T, Sato I, Hiramoto M, Aizawa S, Hatakeyama M, Ohba R, Hatori H, Yoshikawa T, Suzuki F, Oomori A, Tanaka H, Kawaguchi H, Watanabe H, and Handa H. High-performance affinity beads for identifying drug receptors. Nat Biotechnol 18: 877-881, 2000.
79. Sil AK, Maeda S, Sano Y, Roop DR, and Karin M. IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 428: 660-664, 2004.
80. Szabo C, Ischiropoulos H, and Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 6: 662-680, 2007.
81. Toledano MB, Ghosh D, Trinh F, and Leonard WJ. N-terminal DNA-binding domains contribute to differential DNA-binding specificities of NF-kappa B p50 and p65. Mol Cell Biol 13: 852-860, 1993.
82. Toledano MB and Leonard WJ. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci USA 88: 4328-4332, 1991.
83. Tonks NK. Redox redux: revisiting PTPs and the control of cell signaling. Cell 121: 667-670, 2005.
84. Trachootham D, Lu W, Ogasawara MA, Nilsa RD, and Huang P. Redox regulation of cell survival. Antioxid Redox Signal 10: 1343-1374, 2008.
85. Tsai B, Rodighiero C, Lencer WI, and Rapoport TA. Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin. Cell 104: 937-948, 2001.
86. Turpin P, Hay RT, and Dargemont C. Characterization of IkappaBalpha nuclear import pathway. J Biol Chem 274: 6804-6812, 1999.
87. Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, and Haegeman G. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J 22: 1313-1324, 2003.
88. Wagner S, Hofmann A, Siedle B, Terfloth L, Merfort I, and Gasteiger J. Development of a structural model for NF-kappaB inhibition of sesquiterpene lactones using selforganizing neural networks. J Med Chem 49: 2241-2252, 2006.
89. Walker LJ, Robson CN, Black E, Gillespie D, and Hickson ID. Identification of residues in the human DNA repair enzyme HAP1 (Ref-1) that are essential for redox regulation of Jun DNA binding. Mol Cell Biol 13: 5370-5376, 1993.
90. Walling C, Partch RE, and Weil T. Kinetics of the decomposition of hydrogen peroxide catalyzed by ferric ethylene-diaminetetraacetate complex. Proc Natl Acad Sci USA 72: 140-142, 1975.
91. Xia YF, Ye BQ, Li YD, Wang JG, He XJ, Lin X, Yao X, Ma D, Slungaard A, Hebbel RP, Key NS, and Geng JG. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J Immunol 173: 4207-4217, 2004.
92. Yamamoto Y, Verma UN, Prajapati S, Kwak YT, and Gaynor RB. Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature 423: 655-659, 2003.
93. Yang SR, Chida AS, Bauter MR, Shafiq N, Seweryniak K, Maggirwar SB, Kilty I, and Rahman I. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 291: L46-57, 2006.
94. Yang SR, Valvo S, Yao H, Kode A, Rajendrasozhan S, Edirisinghe I, Caito S, Adenuga D, Henry R, Fromm G, Maggirwar S, Li JD, Bulger M, and Rahman I. IKK alpha causes chromatin modification on pro-inflammatory genes by cigarette smoke in mouse lung. Am J Respir Cell Mol Biol 38: 689-698, 2008.
95. Yang XJ and Seto E. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26: 5310-5318, 2007.
96. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, and Mayo MW. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23: 2369-2380, 2004.
97. Zhong H, May MJ, Jimi E, and Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9: 625-636, 2002.
98. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, and Ghosh S. The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89: 413-424, 1997.
99. Zhong H, Voll RE, and Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1: 661-671, 1998.